26 sources live Get alerts
HomeEarnings
Earnings & guidance1 min read

Merck lowers 2026 profit outlook on acquisition-related charges

The pharmaceutical company cut its full-year earnings forecast due to costs tied to its Terns Pharmaceuticals deal
WHY IT MOVED
Acquisition charges are hitting Merck's bottom line even as the company works to integrate Terns Pharmaceuticals into its portfolio.
AT PUBLICATION
MRK127.77▼ -1.87%
Measured when this story was written, not live.
MRK Terns Pharmaceuticals Earnings & guidance Deals & M&A InstantWhy Newsroom 2h ago

The numbers

Yahoo Finance reports that Merck reduced its 2026 profit forecast, citing charges related to its acquisition of Terns Pharmaceuticals. The pharmaceutical company has not independently confirmed the revised guidance. The report did not specify the size of the charge or the updated earnings range.

Why it matters

Deal-related costs typically include one-time expenses for integration, restructuring, and accounting adjustments that depress reported earnings in the near term but are excluded from the adjusted figures analysts use to value the business. Merck previously cut its profit outlook in August while raising its revenue forecast, signaling that top-line growth from new drugs was being offset by deal expenses.

How this compares

Merck lowered its full-year profit forecast on August 4 due to charges tied to the Terns acquisition, even as it raised its revenue outlook on strength in new drug sales. The company had also cut its earnings guidance earlier that same month as acquisition costs weighed on the bottom line. The Terns deal added a pipeline of treatments for metabolic diseases to Merck's portfolio, but the integration costs have repeatedly forced the company to revise its profit expectations downward.

What to watch

Investors will look for detail on the size of the charge and whether Merck's adjusted earnings guidance, which strips out one-time costs, remains intact. The company has not commented on the reported forecast cut or provided a timeline for when integration expenses will subside.

SHARE
HOW THIS STORY WAS MADE

Sources

Artificially generated from public sources, explained in our own words, and published as fast as possible. Our team holds editorial responsibility. This is analysis, not investment advice.

More stories

InstantWhy

Dow rises on easing Strait of Hormuz tensions as Palantir and data storage stocks surge

The blue-chip index gained as geopolitical risk receded, while technology shares rallied on strength in artifi
PLTR ^DJI 2026-08-04 14:43
InstantWhy

Palantir shares surge after earnings beat, though some analysts remain cautious

The data analytics company topped Wall Street forecasts, extending a rally that has pushed the stock higher th
PLTR 2026-08-04 14:23
InstantWhy

Spotify stock sinks as streaming giant's monthly active users forecast misses estimates

Yahoo Finance reports the shares fell after the company's user growth guidance disappointed Wall Street
SPOT 2026-08-04 13:50

Understand the market in five minutes a day

The free daily brief: what moved, and why it moved.

We store your email to send you the brief, nothing else. No tracking, no selling, unsubscribe in one click. Privacy policy.
We're building up to daily — you'll be among the first to get it.

We use no tracking or advertising cookies. If we ever add analytics, they stay off unless you say yes. Cookie policy